Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis blunttruthlaw Views: 624

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Sales of adult-use marijuana will begin in January in Montana.  A new bill would force the FDA to implement CBD regulations.  Mississippi voters are unhappy over the court ruling on medical marijuana.  Connecticut and Rhode Island may join their New England neighbors in legalizing cannabis.  And finally, it’s cicada season in the mid-Atlantic.

montana

Adult-use sales begin in January 2022, under the new law establishing a recreational marijuana market in Montana.  Although this pushes the deadline established by the ballot initiative back by three months, reaction to the law is generally positive.  The law sets limits on the number of plants residents can cultivate at home, and on the amount of THC in retail products.

cbd regulations

Three Senators introduced a bill directing the Food and Drug Administration (FDA) to promulgate rules for the CBD industry.  Sens. Ron Wyden (D-OR), Jeff Merkley (D-OR) and Rand Paul (R-KY) believe that the lack of agency guidance hampers the legitimate CBD industry and causes confusion for consumers.

mississippi

As we reported last week, the Mississippi Supreme Court recently ruled that the state’s ballot initiative process is unconstitutional. This means the medical marijuana program backed by a majority of voters has been thrown out.  This isn’t sitting well with the electorate, who support a special session of the legislature to enact a medical cannabis program.   Further bulletins as events warrant.

connecticut and rhode island

Moving to New England, could two more states legalize adult-use marijuana?  The clock is ticking in Connecticut, where the legislative session ends on June 9.  House members hope to reach agreement this week and move a bill to the Senate next week.

As for Rhode Island, time isn’t quite as short there, but the momentum doesn’t seem as strong either.  A new bill, emphasizing social equity, may gain some traction.

If both states legalized, (note: a BIG if), that would leave New Hampshire as the only states in the region without an adult-use market.  A recent poll found the support for legalization was higher than support for the anti-legalization governor.

and finally

The only topic capable of distracting DC residents from the weather this time of year is the emergence of Brood X cicadas.  Tunneling up from the ground every 17 years, these bugs with the beady red eyes take over much of the area, shedding their exo-skeletons and keeping up a background hum that resembles a buzz saw, but less melodious. They live only a short time, and they spend their few days on the lookout for love.  It’s a bizarre life cycle, made even more weird by a fungus containing psilocybin that attacks the males.

Stay safe and be well everyone – we’ll see you next week!


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.